Karius, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Sample Series to Differentiate Target Nucleic Acids from Contaminant Nucleic Acids (US 11,674,167) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 1 fee due Jan 4, 2027The maintenance fee for Synthetic Nucleic Acid Spike-Ins (US 11,692,224) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
- 1 fee due Jun 5, 2027The maintenance fee for Sample Preparation Methods, Systems and Compositions (US 11,834,711) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 24, 2026
- Oct 6 US 12,753,448 Detection and Prediction of Infectious Disease
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,291,739 | Compositions and Methods for Enriching Populations of Nucleic Acids In force · High confidence | In force | High confidence | |
| US 11,111,520 | Compositions and Methods for Enriching Populations of Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,976,181 | Synthetic Nucleic Acid Spike-Ins In force · High confidence | In force | High confidence | |
| US 11,078,532 | Synthetic Nucleic Acid Spike-Ins In force · High confidence | In force | High confidence | |
| US 11,692,224 | Synthetic Nucleic Acid Spike-Ins In force · High confidence | In force | High confidence | |
| US 12,595,509 | Synthetic Nucleic Acid Spike-Ins In force · High confidence | In force | High confidence | |
| US 11,180,800 | Sample Preparation Methods, Systems and Compositions In force · High confidence | In force | High confidence | |
| US 11,834,711 | Sample Preparation Methods, Systems and Compositions In force · High confidence | In force | High confidence | |
| US 10,697,008 | Sample Preparation Methods, Systems and Compositions In force · High confidence | In force | High confidence | |
| US 11,674,167 | Sample Series to Differentiate Target Nucleic Acids from Contaminant Nucleic Acids In force · Medium confidence | In force | Medium confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending · 4 abandoned
Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/916,558 | Synthetic Nucleic Acid Spike-Ins | Oct 15, 2024 | Pending |
| 18/674,513 | Reduction of Signal from Contaminant Nucleic Acids | May 24, 2024 | Pending |
| 18/610,208 | Microbial Biomarkers in Transplantation and Related Methods | Mar 19, 2024 | Pending |
| 18/527,138 | Sample Series to Differentiate Target Nucleic Acids from Contaminant Nucleic Acids | Dec 1, 2023 | Pending |
| 18/486,005 | Sample Preparation Methods, Systems and Compositions | Oct 12, 2023 | Abandoned |
| 18/365,876 | Metagenomic Next-Generation Sequencing of Microbial Cell-Free Nucleic Acids in Subjects with Lyme Disease | Aug 4, 2023 | Abandoned |
| 18/349,071 | Rapid, Non-Invasive Detection and Serial Monitoring of Infections in Subjects Using Microbial Cell-Free DNA Sequencing | Jul 7, 2023 | Pending |
| 18/338,128 | Sequencing Microbial Cell-Free Nucleic Acids to Detect Inflammation, Secondary Infection, and Disease Severity | Jun 19, 2023 | Pending |
| 17/553,583 | Sequencing Microbial Cell-Free DNA from Asymptomatic Individuals | Dec 16, 2021 | Abandoned |
| 16/263,074 | Reduction of Signal from Contaminant Nucleic Acids | Jan 31, 2019 | Abandoned |